Abstract:
A composition comprising a first compound, a second compound, and a third compound, wherein the first compound, the second compound, and the third compound are different from each other, the first compound satisfies one of Condition 1 and Condition 2 as described herein, and the second compound includes a compound represented by Formula 1: wherein ring A1 is a condensed cyclic group in which 3 or more cyclic groups are condensed with each other, and the 3 or more cyclic groups are each a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; a1 is an integer from 1 to 5; b1 is an integer from 3 to 10; and L1, R1, and R2 are as described herein.
Abstract:
Provided are a heterocyclic compound represented by Formula 1, an organic light-emitting device including the heterocyclic compound, and an electronic apparatus including the organic light-emitting device: wherein Formula 1 may be understood by referring to the description of Formula 1 provided herein.
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: wherein in Formula 1, groups and variables are the same as described in the specification.
Abstract:
A method of producing lactone by converting an aqueous solution including hydroxycarboxylic acid or dicarboxylic acid to lactone under an acid condition and in the presence of a water immiscible solvent.
Abstract:
An organometallic compound represented by Formula 1:
wherein, M1 is a transition metal; X11 is N or C(R11); X12 is N or C(R12); X21 is N or C(R21); X22 is N or C(R22); X23 is N or C(R23); at least one of X21 and X22 is N; Y2 to Y4 are each independently C or N; A2 to A4 are each independently a chemical bond, O, or S; ring CY3 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; a1, a2, and a3 are each independently an integer from 1 to 3; R13 is a group represented by Formula 2, and the remaining substituents are as defined herein.
Abstract:
An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound are provided:
M1(L11)n11(L12)n12 Formula 1
wherein, in Formula 1, L11 may be a ligand represented by Formula 1-1, and the other substituents may be understood by referring to the descriptions thereof provided in the detailed description:
Abstract:
An organometallic compound represented by Formula 1: M1(L11)n11(L12)n12 Formula 1 wherein, in Formula 1, M1 is a first-row transition metal, a second-row transition metal, or a third-row transition metal, L11 is a ligand represented by Formula 1-1, L12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2: wherein ring CY1 to ring CY4, E1, T1 to T4, R10 to R40, X1 to X4, n1 to n4, a1 to a4, and c10 to c40 may each be understood by referring to the descriptions thereof provided herein, and *1, *2, *3, and *4 are each a binding site to M1 in Formula 1.
Abstract:
A method for preparing a hydrogenation catalyst by mixing a copper salt with colloidal silica to form a precipitate, washing the formed precipitate to remove anions of the copper salt from the precipitate, and impregnating the anion-removed precipitate with an alkali metal to form a hydrogenation catalyst; and a method for preparing a diol from a lactone using the hydrogenation catalyst.
Abstract:
A thermoplastic resin composition including: a polylactic acid; an inorganic nanostructure; and a chain extender, a molded article made of the thermoplastic resin, and a method of preparing the thermoplastic resin composition are disclosed.